101 related articles for article (PubMed ID: 21142704)
1. Induction of multinucleation in oral squamous cell carcinoma tissue with mutated p53 surviving boron neutron capture therapy.
Fujita Y; Yamamoto N; Kato I; Iwai S; Ono K; Sakurai Y; Ohnishi K; Ohnishi T; Yura Y
Int J Radiat Biol; 2011 Mar; 87(3):293-301. PubMed ID: 21142704
[TBL] [Abstract][Full Text] [Related]
2. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
[TBL] [Abstract][Full Text] [Related]
3. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
4. Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells.
Kamida A; Fujita Y; Kato I; Iwai S; Ono K; Suzuki M; Sakurai Y; Yura Y
Int J Radiat Biol; 2008 Mar; 84(3):191-9. PubMed ID: 18300019
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model.
Kreimann EL; Itoiz ME; Longhino J; Blaumann H; Calzetta O; Schwint AE
Cancer Res; 2001 Dec; 61(24):8638-42. PubMed ID: 11751376
[TBL] [Abstract][Full Text] [Related]
6. Disposition of TF-PEG-Liposome-BSH in tumor-bearing mice.
Ito Y; Kimura Y; Shimahara T; Ariyoshi Y; Shimahara M; Miyatake S; Kawabata S; Kasaoka S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S109-10. PubMed ID: 19395268
[TBL] [Abstract][Full Text] [Related]
7. Role of p53 mutation in the effect of boron neutron capture therapy on oral squamous cell carcinoma.
Fujita Y; Kato I; Iwai S; Ono K; Suzuki M; Sakurai Y; Ohnishi K; Ohnishi T; Yura Y
Radiat Oncol; 2009 Dec; 4():63. PubMed ID: 20003329
[TBL] [Abstract][Full Text] [Related]
8. The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine.
Kreimann EL; Itoiz ME; Dagrosa A; Garavaglia R; Farías S; Batistoni D; Schwint AE
Cancer Res; 2001 Dec; 61(24):8775-81. PubMed ID: 11751398
[TBL] [Abstract][Full Text] [Related]
9. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy.
Dagrosa MA; Viaggi M; Rebagliati RJ; Batistoni D; Kahl SB; Juvenal GJ; Pisarev MA
Mol Pharm; 2005; 2(2):151-6. PubMed ID: 15804189
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
12. Optimization of boron neutron capture therapy for the treatment of undifferentiated thyroid cancer.
Dagrosa MA; Thomasz L; Longhino J; Perona M; Calzetta O; Blaumann H; Rebagliati RJ; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1059-66. PubMed ID: 17967301
[TBL] [Abstract][Full Text] [Related]
13. Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas.
Yamatomo N; Iwagami T; Kato I; Masunaga S; Sakurai Y; Iwai S; Nakazawa M; Ono K; Yura Y
Radiat Oncol; 2013 Dec; 8():280. PubMed ID: 24295213
[TBL] [Abstract][Full Text] [Related]
14. Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors.
Takagaki M; Ono K; Oda Y; Kikuchi H; Nemoto H; Iwamoto S; Cai J; Yamamoto Y
Cancer Res; 1996 May; 56(9):2017-20. PubMed ID: 8616843
[TBL] [Abstract][Full Text] [Related]
15. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
[TBL] [Abstract][Full Text] [Related]
16. Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch.
Heber E; Trivillin VA; Nigg D; Kreimann EL; Itoiz ME; Rebagliati RJ; Batistoni D; Schwint AE
Arch Oral Biol; 2004 Apr; 49(4):313-24. PubMed ID: 15003550
[TBL] [Abstract][Full Text] [Related]
17. Improvement of the tumor-suppressive effect of boron neutron capture therapy for amelanotic melanoma by intratumoral injection of the tyrosinase gene.
Morita N; Hiratsuka J; Kondoh H; Uno M; Asano T; Niki Y; Sakurai Y; Ono K; Harada T; Imajo Y
Cancer Res; 2006 Apr; 66(7):3747-53. PubMed ID: 16585201
[TBL] [Abstract][Full Text] [Related]
18. First evaluation of the biologic effectiveness factors of boron neutron capture therapy (BNCT) in a human colon carcinoma cell line.
Dagrosa MA; Crivello M; Perona M; Thorp S; Santa Cruz GA; Pozzi E; Casal M; Thomasz L; Cabrini R; Kahl S; Juvenal GJ; Pisarev MA
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):262-8. PubMed ID: 20932650
[TBL] [Abstract][Full Text] [Related]
19. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
[TBL] [Abstract][Full Text] [Related]
20. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
